As a continuation of earlier studies showing higher proGRP serum concentration in benign non-inflammatory lung diseases and studies showing differentiation of NSCLC from the SCLC by proGRP, our study has shown the disparity in proGRP between the early-stage ADC or SQCC and COPD and pneumonia (11, 15, 28). Here, GRP is linked to susceptibility to pneumonia measurement.